2seventy bio, Inc.
NASDAQ:TSVT
Overview | Financials
| Company Name | 2seventy bio, Inc. |
| Symbol | TSVT |
| Currency | USD |
| Price | 5 |
| Market Cap | 266,141,500 |
| Dividend Yield | 0% |
| 52-week-range | 2.29 - 5.3 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Mr. Nick Leschly |
| Website | https://www.2seventybio.com |
An error occurred while fetching data.
About 2seventy bio, Inc.
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD








